{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T17:04:39Z","timestamp":1779728679594,"version":"3.53.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ando.2026.102516","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:37:15Z","timestamp":1773941835000},"page":"102516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia"],"prefix":"10.1016","volume":"87","author":[{"given":"Fanny","family":"Chasseloup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ando.2026.102516_bib0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO Classification of Adrenal Cortical Tumors","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.ando.2026.102516_bib0330","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/jcem-24-10-947","article-title":"Cushing's syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor","volume":"24","author":"Kirschner","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.ando.2026.102516_bib0335","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ando.2026.102516_bib0340","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.ando.2026.102516_bib0345","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41574-022-00718-y","article-title":"Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease","volume":"18","author":"Cavalcante","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0350","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A inactivation causes hereditary food-dependent Cushing syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12022-023-09751-7","article-title":"Impact of morphology in the genotype and phenotype correlation of bilateral macronodular adrenocortical disease (BMAD): a series of clinicopathologically well-characterized 35 cases","volume":"34","author":"Violon","year":"2023","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.ando.2026.102516_bib0360","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.ando.2026.102516_bib0370","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2026.102516_bib0375","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2169\/internalmedicine.36.536","article-title":"Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas\/carcinomas which showed a point mutation in the APC gene","volume":"36","author":"Yamakita","year":"1997","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0380","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0385","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13023-025-03554-1","article-title":"The mutational landscape of ARMC5 in primary bilateral macronodular adrenal hyperplasia: an update","volume":"20","author":"Bouys","year":"2025","journal-title":"Orphanet J Rare Dis"},{"issue":"16","key":"10.1016\/j.ando.2026.102516_bib0395","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151390","article-title":"ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors","volume":"7","author":"Okuno","year":"2022","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.ando.2026.102516_bib0400","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1093\/nar\/gkac483","article-title":"ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia","volume":"50","author":"Lao","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.ando.2026.102516_bib0405","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-19-0502","article-title":"Cullin 3 targets the tumor suppressor gene ARMC5 for ubiquitination and degradation","volume":"27","author":"Cavalcante","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2026.102516_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2017.06.027","article-title":"The role of ARMC5 in human cell cultures from nodules of primary macronodular adrenocortical hyperplasia (PMAH)","volume":"460","author":"Cavalcante","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.ando.2026.102516_bib0415","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa075","article-title":"Molecular basis of primary aldosteronism and adrenal Cushing syndrome","volume":"4","author":"Vaduva","year":"2020","journal-title":"J Endocr Soc"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0420","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-1032","article-title":"Identification of predictive criteria for pathogenic variants of the primary bilateral macronodular adrenal hyperplasia gene ARMC5 in 352 unselected patients","volume":"187","author":"Bouys","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0425","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-21-1032","article-title":"Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients","volume":"187","author":"Bouys","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0430","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0435","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.ando.2026.102516_bib0440","doi-asserted-by":"crossref","first-page":"E1501","DOI":"10.1210\/jc.2013-4237","article-title":"ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia","volume":"99","author":"Alencar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/EJE-15-0642","article-title":"ARMC5 mutations in a large French-Canadian family with cortisol-secreting beta-adrenergic\/vasopressin responsive bilateral macronodular adrenal hyperplasia","volume":"174","author":"Bourdeau","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2026.102516_bib0450","doi-asserted-by":"crossref","first-page":"8848151","DOI":"10.1155\/2020\/8848151","article-title":"ARMC5 primary bilateral macronodular adrenal hyperplasia associated with a meningioma: a family report","volume":"2020","author":"Ferreira","year":"2020","journal-title":"Case Rep Endocrinol"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0455","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-20-0014","article-title":"Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report","volume":"183","author":"Jojima","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ando.2026.102516_bib0460","first-page":"3531","article-title":"Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?","volume":"85","author":"Mircescu","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2026.102516_bib0465","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Libe","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2026.102516_bib0475","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1750-1172-8-142","article-title":"ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11\u03b2-hydroxylase","volume":"8","author":"Hofland","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0480","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1172\/JCI106608","article-title":"Abnormal hormone responses of an adrenocortical cancer adenyl cyclase","volume":"50","author":"Schorr","year":"1971","journal-title":"J Clin Invest"},{"issue":"18","key":"10.1016\/j.ando.2026.102516_bib0485","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.1016\/S0021-9258(18)61876-9","article-title":"Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma","volume":"246","author":"Schorr","year":"1971","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0490","first-page":"530","article-title":"Cushing syndrome with food-dependent periodic hormonogenesis","volume":"10","author":"Hamet","year":"1987","journal-title":"Clin Invest Med"},{"issue":"14","key":"10.1016\/j.ando.2026.102516_bib0495","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ando.2026.102516_bib0500","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.ando.2026.102516_bib0505","first-page":"3168","article-title":"Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells","volume":"81","author":"de Herder","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.ando.2026.102516_bib0510","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jcem.83.8.5038","article-title":"Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome","volume":"83","author":"N\u2019Diaye","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"10.1016\/j.ando.2026.102516_bib0515","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3109\/07435809809032696","article-title":"Gastric inhibitory polypeptide (GIP) stimulates cortisol secretion, cAMP production and DNA synthesis in an adrenal adenoma responsible for food-dependent Cushing's syndrome","volume":"24","author":"Chabre","year":"1998","journal-title":"Endocr Res"},{"issue":"18","key":"10.1016\/j.ando.2026.102516_bib0520","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.ando.2026.102516_bib0525","doi-asserted-by":"crossref","first-page":"M121","DOI":"10.1530\/EJE-15-0532","article-title":"Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?","volume":"173","author":"Drougat","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0530","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/ERC-20-0128","article-title":"Genomic classification of benign adrenocortical lesions","volume":"28","author":"Faillot","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.ando.2026.102516_bib0535","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","article-title":"Histone demethylation mediated by the nuclear amine oxidase homolog LSD1","volume":"119","author":"Shi","year":"2004","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ando.2026.102516_bib0540","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrm3327","article-title":"Molecular mechanisms and potential functions of histone demethylases","volume":"13","author":"Kooistra","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ando.2026.102516_bib0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: a dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0550","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.molcel.2005.08.027","article-title":"Regulation of LSD1 histone demethylase activity by its associated factors","volume":"19","author":"Shi","year":"2005","journal-title":"Mol Cell"},{"issue":"8","key":"10.1016\/j.ando.2026.102516_bib0555","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/epi-2016-0009","article-title":"LSD1: biologic roles and therapeutic targeting","volume":"8","author":"Maiques-Diaz","year":"2016","journal-title":"Epigenomics"},{"issue":"17","key":"10.1016\/j.ando.2026.102516_bib0560","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00018-020-03489-9","article-title":"Biological roles of LSD1 beyond its demethylase activity","volume":"77","author":"Gu","year":"2020","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0565","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ejendo\/lvaf016","article-title":"KDM1A genetic alterations, a rare cause of primary bilateral macronodular adrenal hyperplasia, strongly associated with food-dependent Cushing's syndrome: results of its systematic germline screening in 301 index cases and genotype\/phenotype correlation","volume":"192","author":"Bouys","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ando.2026.102516_bib0570","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1158\/0008-5472.CAN-17-1900","article-title":"Germline lysine-specific demethylase 1 (LSD1\/KDM1A) mutations confer susceptibility to multiple myeloma","volume":"78","author":"Wei","year":"2018","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0575","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"10.1016\/j.ando.2026.102516_bib0580","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2002-021362","article-title":"Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene","volume":"88","author":"Fragoso","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ando.2026.102516_bib0585","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Lib\u00e9","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0590","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"10.1016\/j.ando.2026.102516_bib0595","doi-asserted-by":"crossref","first-page":"e2946","DOI":"10.1210\/clinem\/dgae918","article-title":"PDE11A is a phenotype modulator of primary bilateral macronodular adrenal hyperplasia: results of a 334-patient series","volume":"110","author":"Vaduva","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.ando.2026.102516_bib0600","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0605","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"5311","key":"10.1016\/j.ando.2026.102516_bib0610","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ando.2026.102516_bib0615","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-5347(05)66068-5","article-title":"Multiple endocrine neoplasia type 1 and adrenal lesions","volume":"166","author":"Barzon","year":"2001","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ando.2026.102516_bib0620","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00423-006-0124-7","article-title":"Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening","volume":"392","author":"Waldmann","year":"2007","journal-title":"Langenbecks Arch Surg"},{"issue":"6","key":"10.1016\/j.ando.2026.102516_bib0625","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.ando.2026.102516_bib0630","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0092-8674(00)00122-7","article-title":"Linking colorectal cancer to Wnt signaling","volume":"103","author":"Bienz","year":"2000","journal-title":"Cell"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426626000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T16:26:16Z","timestamp":1779726376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426626000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0003426626000375"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2026.102516","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KDM1A pathogenic variants link epigenetic regulation to GIP-dependent primary bilateral macronodular adrenal hyperplasia","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2026.102516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102516"}}